Mission Hospital Inc
- Type
- Teaching hospital
- Where
- Spokane, WA
- Medicare CCN
- 340002
- Received
- $812,535 in 172 records, 2020 ($60,433 general, $752,102 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2020 | General payment | 10 | $60,433 |
| 2020 | Research payment | 162 | $752,102 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Allergan, Inc. | 18 | $413,612 | 2020 |
| Abbott Laboratories | 22 | $129,385 | 2020 |
| Amgen Inc. | 11 | $67,036 | 2020 |
| GE HEALTHCARE | 2 | $42,088 | 2020 |
| Medtronic Vascular, Inc. | 21 | $41,117 | 2020 |
| W. L. Gore & Associates, Inc. | 7 | $31,672 | 2020 |
| Bolton Medical Inc | 12 | $22,750 | 2020 |
| Surmodics, Inc. | 11 | $17,620 | 2020 |
| Medartis Inc. | 1 | $7,422 | 2020 |
| BIOTRONIK INC. | 47 | $6,722 | 2020 |
| Genentech, Inc. | 3 | $6,496 | 2020 |
| Smith+Nephew, Inc. | 1 | $6,305 | 2020 |
| Edwards Lifesciences Corporation | 2 | $5,870 | 2020 |
| Stryker Corporation | 4 | $5,867 | 2020 |
| Linvatec Corporation | 1 | $2,164 | 2020 |
| ABBVIE INC. | 2 | $2,125 | 2020 |
| AstraZeneca Pharmaceuticals LP | 2 | $1,750 | 2020 |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,285 | 2020 |
| Aesculap Implant Systems, LLC | 1 | $577 | 2020 |
| Siemens Medical Solutions USA, Inc. | 1 | $375 | 2020 |
| Zimmer Biomet Holdings, Inc. | 1 | $227 | 2020 |
| Olympus America Inc. | 1 | $63 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 162 | $752,102 |
| Royalty or License | 1 | $41,000 |
| Gift | 5 | $15,578 |
| Grant | 1 | $2,164 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $1,088 |
| Charitable Contribution | 1 | $375 |
| Honoraria | 1 | $227 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | Allergan, Inc. | $216,129 | Research payment | In-kind items and services | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-12-31 | W. L. Gore & Associates, Inc. | $7,955 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GREAT Global Registry for Endovascular Aortic Treatment | 2020 |
| 2020-12-31 | Medartis Inc. | $7,422 | Gift | In-kind items and services | APTUS Device, ORTHO | 2020 | |
| 2020-12-31 | Stryker Corporation | $1,208 | Gift | Cash or cash equivalent | NONE Device, NONE | 2020 | |
| 2020-12-31 | AstraZeneca Pharmaceuticals LP | $239 | Research payment | In-kind items and services | EPANOVA Drug, Cardiovascular and Metabolism | A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs wi | 2020 |
| 2020-12-31 | Zimmer Biomet Holdings, Inc. | $227 | Honoraria | In-kind items and services | Zimmer Biomet Instruments and Implants Device, Medical Device | 2020 | |
| 2020-12-25 | Amgen Inc. | $1,250 | Research payment | Cash or cash equivalent | Neulasta Biological, Oncology | Prospective Observational Study of Onpro vs SOC. | 2020 |
| 2020-12-24 | Amgen Inc. | $5,107 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-12-24 | Amgen Inc. | $548 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-12-17 | Genentech, Inc. | $2,253 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS | 2020 |
| 2020-12-16 | Medtronic Vascular, Inc. | $1,735 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-12-11 | Aesculap Implant Systems, LLC | $577 | Gift | Cash or cash equivalent | 2020 | ||
| 2020-12-09 | ABBVIE INC. | $500 | Research payment | Cash or cash equivalent | M12-914 | 2020 | |
| 2020-12-04 | Medtronic Vascular, Inc. | $500 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-11-30 | Linvatec Corporation | $2,164 | Grant | In-kind items and services | IFS Device, GENERAL SURGERY | 2020 | |
| 2020-11-18 | Medtronic Vascular, Inc. | $512 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-11-17 | Allergan, Inc. | $18,076 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-11-16 | Medtronic Vascular, Inc. | $950 | Research payment | Cash or cash equivalent | Heli-FX EndoAnchor System Device, Aortic EndoAnchors | ANCHOR Registry | 2020 |
| 2020-11-12 | ABBVIE INC. | $1,625 | Research payment | Cash or cash equivalent | M12-914 | 2020 | |
| 2020-11-11 | Abbott Laboratories | $2,386 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-11-11 | Medtronic Vascular, Inc. | $1,024 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-11-10 | E.R. Squibb & Sons, L.L.C. | $1,285 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | A Phase IIIb/IV Safety Trial of Nivolumab (BMS-936558) in Subjects with Advanced or Metastatic Non-Small Cell Lung Cance | 2020 |
| 2020-11-05 | Surmodics, Inc. | $750 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-11-05 | Surmodics, Inc. | $500 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-11-04 | Abbott Laboratories | $8,697 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-11-04 | Abbott Laboratories | $8,697 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-11-04 | Stryker Corporation | $2,825 | Research payment | Cash or cash equivalent | TRIATHLON Device, KNEES | TRIATHLON TRITANIUM KNEE OUTCOMES STUDY | 2020 |
| 2020-10-28 | Abbott Laboratories | $3,679 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Vascular | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-10-26 | Medtronic Vascular, Inc. | $512 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-10-23 | Amgen Inc. | $6,544 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-10-15 | Allergan, Inc. | $6,812 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-10-15 | Medtronic Vascular, Inc. | $3,622 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-10-15 | Surmodics, Inc. | $1,464 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-10-15 | Abbott Laboratories | $375 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Vascular | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-10-15 | Abbott Laboratories | $375 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Vascular | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-10-01 | GE HEALTHCARE | $41,000 | Royalty or License | Cash or cash equivalent | 2020 | ||
| 2020-09-29 | Siemens Medical Solutions USA, Inc. | $375 | Charitable Contribution | Cash or cash equivalent | 2020 | ||
| 2020-09-22 | AstraZeneca Pharmaceuticals LP | $1,510 | Research payment | Cash or cash equivalent | EPANOVA Drug, Cardiovascular and Metabolism | A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs wi | 2020 |
| 2020-09-17 | Edwards Lifesciences Corporation | $5,120 | Research payment | Cash or cash equivalent | EDWARDS INTUITY Elite valve system Device, Pericardial Heart Valves | TRANSFORM 2011-02 | 2020 |
| 2020-09-17 | Edwards Lifesciences Corporation | $750 | Research payment | Cash or cash equivalent | EDWARDS INTUITY Elite valve system Device, Pericardial Heart Valves | TRANSFORM 2011-02 | 2020 |
| 2020-09-16 | Allergan, Inc. | $3,124 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-09-16 | Bolton Medical Inc | $2,550 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-09-14 | Allergan, Inc. | $12,924 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-09-09 | Stryker Corporation | $750 | Research payment | Cash or cash equivalent | TRITANIUM Device, HIPS | TRIATHLON TRITANIUM KNEE OUTCOMES STUDY | 2020 |
| 2020-08-31 | Bolton Medical Inc | $4,950 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-08-31 | Bolton Medical Inc | $4,400 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-08-31 | Bolton Medical Inc | $1,100 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-08-31 | Bolton Medical Inc | $100 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-08-30 | Smith+Nephew, Inc. | $6,305 | Gift | In-kind items and services | GENESIS II Device, Recon Knees | 2020 | |
| 2020-08-27 | Abbott Laboratories | $4,065 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-08-27 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-08-27 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-08-27 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-08-26 | Medtronic Vascular, Inc. | $940 | Research payment | Cash or cash equivalent | Arctic Front Device, Ablation | STOP Persistent AF | 2020 |
| 2020-08-22 | Amgen Inc. | $1,250 | Research payment | Cash or cash equivalent | Neulasta Biological, Oncology | Prospective Observational Study of Onpro vs SOC. | 2020 |
| 2020-08-17 | Allergan, Inc. | $21,697 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-08-12 | Abbott Laboratories | $3,593 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-08-12 | Abbott Laboratories | $3,593 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-08-11 | Allergan, Inc. | $3,000 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-08-07 | Allergan, Inc. | $1,000 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-08-07 | Allergan, Inc. | $700 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-08-06 | Medtronic Vascular, Inc. | $5,281 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-08-05 | Abbott Laboratories | $1,352 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-07-29 | Abbott Laboratories | $5,083 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-07-28 | Bolton Medical Inc | $7,000 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-07-28 | Bolton Medical Inc | $1,100 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-07-27 | Allergan, Inc. | $5,200 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-07-15 | Allergan, Inc. | $26,323 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-07-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $207 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $166 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-14 | BIOTRONIK INC. | $9 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-07-13 | Medtronic Vascular, Inc. | $1,815 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-07-09 | Amgen Inc. | $240 | Research payment | In-kind items and services | GALACTIC - HF | 2020 | |
| 2020-07-06 | W. L. Gore & Associates, Inc. | $1,587 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GREAT Global Registry for Endovascular Aortic Treatment | 2020 |
| 2020-07-06 | Allergan, Inc. | $750 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-06-30 | Bolton Medical Inc | $100 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-06-29 | Medtronic Vascular, Inc. | $300 | Research payment | Cash or cash equivalent | Arctic Front Device, Ablation | STOP Persistent AF | 2020 |
| 2020-06-25 | Genentech, Inc. | $1,989 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS | 2020 |
| 2020-06-25 | Medtronic Vascular, Inc. | $468 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-06-25 | Medtronic Vascular, Inc. | $384 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-06-25 | Medtronic Vascular, Inc. | $384 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-06-24 | Bolton Medical Inc | $750 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-06-18 | Surmodics, Inc. | $7,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-06-18 | Surmodics, Inc. | $2,000 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-06-18 | Surmodics, Inc. | $750 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-06-16 | Allergan, Inc. | $2,987 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-06-12 | W. L. Gore & Associates, Inc. | $750 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GORE EXCLUDER Conformable Endoprosthesis | 2020 |
| 2020-06-11 | Medtronic Vascular, Inc. | $726 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-06-10 | Medtronic Vascular, Inc. | $9,400 | Research payment | Cash or cash equivalent | Heli-FX EndoAnchor System Device, Aortic EndoAnchors | ANCHOR Registry | 2020 |
| 2020-06-09 | Bolton Medical Inc | $50 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-06-05 | W. L. Gore & Associates, Inc. | $2,126 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GORE EXCLUDER Conformable Endoprosthesis | 2020 |
| 2020-05-13 | Abbott Laboratories | $2,153 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-05-08 | Surmodics, Inc. | $1,627 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-05-08 | Surmodics, Inc. | $1,627 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-05-06 | Abbott Laboratories | $28,883 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-05-06 | Stryker Corporation | $1,084 | Research payment | Cash or cash equivalent | TRITANIUM Device, HIPS | TRIATHLON TRITANIUM KNEE OUTCOMES STUDY | 2020 |
| 2020-04-23 | Medtronic Vascular, Inc. | $190 | Research payment | Cash or cash equivalent | Arctic Front Device, Ablation | STOP Persistent AF | 2020 |
| 2020-04-22 | Abbott Laboratories | $10,411 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-04-17 | W. L. Gore & Associates, Inc. | $11,404 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GREAT Global Registry for Endovascular Aortic Treatment | 2020 |
| 2020-04-14 | Allergan, Inc. | $12,025 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-04-10 | W. L. Gore & Associates, Inc. | $6,348 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GREAT Global Registry for Endovascular Aortic Treatment | 2020 |
| 2020-04-08 | Allergan, Inc. | $6,248 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-04-07 | BIOTRONIK INC. | $1,000 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-04-07 | Medtronic Vascular, Inc. | $726 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-03-31 | Genentech, Inc. | $2,253 | Research payment | Cash or cash equivalent | Non-Covered Product Drug, None | TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS | 2020 |
| 2020-03-31 | BIOTRONIK INC. | $500 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2020 |
| 2020-03-27 | Medtronic Vascular, Inc. | $2,319 | Research payment | Cash or cash equivalent | Arctic Front Device, Ablation | STOP Persistent AF | 2020 |
| 2020-03-16 | Allergan, Inc. | $21,208 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-03-06 | Medtronic Vascular, Inc. | $8,079 | Research payment | Cash or cash equivalent | Viva Device, Implantable Cardioverter Defibrillators (ICDs) | AdaptResponse | 2020 |
| 2020-03-04 | Surmodics, Inc. | $1,627 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-03-04 | Surmodics, Inc. | $175 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-03-04 | Surmodics, Inc. | $100 | Research payment | Cash or cash equivalent | SurVeil Device, Drug-Coated Balloon | TRANSCEND | 2020 |
| 2020-03-02 | Amgen Inc. | $20,005 | Research payment | In-kind items and services | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-02-28 | GE HEALTHCARE | $1,088 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2020 | ||
| 2020-02-25 | Amgen Inc. | $242 | Research payment | In-kind items and services | GALACTIC - HF | 2020 | |
| 2020-02-20 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Trifecta Valve Device, Cardiac Arrhythmias and Heart Failure | Long Term Follow Up of the St. Jude Medical Trifecta Valve | 2020 |
| 2020-02-13 | Allergan, Inc. | $38,343 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-02-12 | Abbott Laboratories | $19,773 | Research payment | Cash or cash equivalent | Portico Transcatheter Aortic HV Device, Cardiac Arrhythmias and Heart Failure | Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) | 2020 |
| 2020-02-12 | Abbott Laboratories | $10,679 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $265 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-11 | BIOTRONIK INC. | $33 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-02-04 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | Arctic Front Device, Ablation | STOP Persistent AF | 2020 |
| 2020-01-31 | Amgen Inc. | $24,816 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | VESALIUS - CV | 2020 |
| 2020-01-30 | Amgen Inc. | $6,803 | Research payment | Cash or cash equivalent | GALACTIC - HF | 2020 | |
| 2020-01-30 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Tendyne Mitral Valve System Device, Cardiac Arrhythmias and Heart Failure | Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Sy | 2020 |
| 2020-01-29 | BIOTRONIK INC. | $1,500 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2020 |
| 2020-01-28 | Olympus America Inc. | $63 | Gift | In-kind items and services | Olympus Otology Devices Device, ENT Products | 2020 | |
| 2020-01-24 | W. L. Gore & Associates, Inc. | $1,500 | Research payment | Cash or cash equivalent | Product in Development Device, Devices | GREAT Global Registry for Endovascular Aortic Treatment | 2020 |
| 2020-01-22 | Abbott Laboratories | $11,087 | Research payment | Cash or cash equivalent | Amplatzer Amulet LAAO Device, Cardiac Arrhythmias and Heart Failure | AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial | 2020 |
| 2020-01-16 | Allergan, Inc. | $17,061 | Research payment | Cash or cash equivalent | A multi-centered, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety o | 2020 | |
| 2020-01-14 | Bolton Medical Inc | $150 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-01-09 | Bolton Medical Inc | $500 | Research payment | Cash or cash equivalent | RelayPro Device, Device | RelayPro | 2020 |
| 2020-01-09 | Amgen Inc. | $229 | Research payment | In-kind items and services | GALACTIC - HF | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Spokane, WA, county Spokane County, WA, state Washington; placed by its city name.
| Measure | Place (city or town) Spokane, WA | County Spokane County, WA | State Washington |
|---|---|---|---|
| Population B01003 | 230,293 | 549,056 | 7,816,116 |
| Population, 2020 census P1 | 228,989 | 539,339 | 7,705,281 |
| Median age B01002 | 37.2 | 38.5 | 38.3 |
| Under 18 B01001 | 20.4% | 21.5% | 21.4% |
| 65 and over B01001 | 16.6% | 17.4% | 16.6% |
| Households B11001 | 97,446 | 218,395 | 3,064,820 |
| Foreign born B05002 | 6.0% | 5.4% | 15.4% |
| Median household income B19013 | $70,064 | $78,582 | $98,141 |
| Median family income B19113 | $92,514 | $100,388 | $118,075 |
| Per capita income B19301 | $40,080 | $41,897 | $53,744 |
| Poverty rate B17001 | 13.8% | 11.7% | 9.9% |
| Unemployment rate B23025 | 5.7% | 5.3% | 5.1% |
| Civilian labor force B23025 | 118,395 | 271,706 | 4,024,423 |
| Mean commute (minutes) B08013 | 20.6 | 22.5 | 26.6 |
| Bachelor's degree or higher B15003 | 33.9% | 33.1% | 39.6% |
| Housing units B25001 | 102,834 | 231,205 | 3,306,620 |
| Owner-occupied B25003 | 58.8% | 64.5% | 63.8% |
| Renters B25003 | 41.2% | 35.5% | 36.2% |
| Median home value B25077 | $363,500 | $410,700 | $564,600 |
| Median gross rent B25064 | $1,215 | $1,283 | $1,760 |
| White, not Hispanic B03002 | 77.6% | 80.9% | 63.1% |
| Black B03002 | 2.8% | 1.9% | 3.8% |
| Hispanic or Latino B03002 | 8.4% | 7.1% | 14.4% |
| Asian B03002 | 2.5% | 2.2% | 9.7% |
| American Indian and Alaska Native B03002 | 0.8% | 0.7% | 0.8% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Spokane, WA.
Comments